2585 studies found for:    ovarian cancer
Show Display Options
Rank Status Study
21 Recruiting Detection of Chlamydia DNA by Polymerase Chain Reaction in Primary Tubal and Ovarian Cancers Tissues : a Pilot Study
Condition: Malignant Neoplasm of Fallopian Tube
Intervention: Other: PCR for chlamydia DNA in primary tubal cancer
22 Unknown  A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Paclitaxel, Carboplatin and Vorinostat
23 Active, not recruiting Epithelial Ovarian Cancer- Staging and Response to Chemotherapy Evaluated by PET/CT
Conditions: Epithelial Ovarian Cancer;   Peritoneal Cancer;   Fallopian Tube Cancer
Intervention:
24 Terminated NYU Ovarian Cancer Early Detection Program Blood and Genetics
Condition: Ovarian Cancer
Intervention:
25 Recruiting Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Procedure: ovarian cancer surgery
26 Terminated Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer
Conditions: Ovarian Cancer;   Epithelial Ovarian Cancer;   Fallopian Tube Carcinoma;   Primary Peritoneal Carcinoma
Interventions: Drug: Lenalidomide, Liposomal Doxorubicin, Bevacizumab;   Drug: Revlimid, Doxil, Avastin
27 Completed Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot Study
Condition: Ovarian Cancer
Intervention: Procedure: DCE-MRI scans
28 Terminated Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer
Conditions: Ovarian Diseases;   Ovarian Neoplasms
Interventions: Other: Laboratory Tumor Marker Analysis;   Other: Transvaginal Ultrasound;   Other: Health Status Questionnaire
29 Recruiting A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer
Conditions: Ovarian Cancer;   Breast Cancer;   Prostate Cancer
Intervention: Drug: LY2606368
30 Completed First Line Ovarian Cancer Treatment - Cohort Study
Condition: Epithelial Ovarian Cancer
Intervention: Drug: Bevacizumab
31 Completed Prostaglandin Metabolite in Urine Samples From Patients With Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Genetic: protein expression analysis;   Other: immunohistochemistry
32 Completed
Has Results
Open Trial of Bendamustine Hydrochloride in Women With Advanced Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Bendamustine HCL
33 Recruiting Observational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian Cancer
Conditions: Low-grade Serous Ovarian Carcinoma;   Recurrent Invasive Borderline Serous Ovarian Cancer
Intervention:
34 Active, not recruiting AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer
Conditions: Breast Cancer;   Ovarian Cancer
Intervention: Drug: AZ2281 + Carboplatin
35 Active, not recruiting Feasibility Study: Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients
Conditions: Ovarian Cancer;   Primary Peritoneal Carcinoma;   Fallopian Tube Cancer
Interventions: Drug: Propranolol;   Drug: Chemotherapy;   Procedure: Surgery;   Behavioral: Questionnaire
36 Active, not recruiting Chemotherapy-Related Toxicities In Ovarian Cancer Patients
Condition: Ovarian Cancer
Interventions: Behavioral: Interview;   Behavioral: Questionnaire
37 Terminated Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemotherapy for Advanced Ovarian Cancer
Condition: Epithelial Ovarian Cancer
Intervention: Procedure: Seprafilm™
38 Completed M. D. Anderson Symptom Inventory - Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Behavioral: Interview;   Behavioral: Survey
39 Active, not recruiting Prevalence of BRCA in Patients With Ovarian Cancer
Conditions: BRCA Status;   Ovarian Cancer
Intervention: Genetic: Testing of BRCA status regarding germline and somatic mutation
40 Withdrawn Cost Utility Analysis in Recurrent Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Behavioral: Questionnaire

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years